Cannabis Science Inc.
Cannabis Science Inc.
Home
About Us
Corporate Overview
Mission Statement
Cannabis Science Team
Careers & Corporate Culture
iCannabinoid
Join Now!
R&D
The Science of Cannabinoids
CBIS Cannabinoid Research
Critical Ailments
COLLABORATIONS & PROJECTS
CBIS Medical Consortium
Global Economic Development
Pan African A & C University
African Economic Initiative
American States University
North American Economic Initiative
Dana-Farber
CFA
Stellenbosch University
CBIS Bottle It
Products & Pharmacies
Products
Order Online
Pharmacies
Investors
CBIS Current Share Structure
SEC Filings
Media
CBIS News Releases
CBIS In The News
CBIS Events
Contact
latest Articles
Cannabis Science Issues 2019 Guidance Report; Under SEC Sanctions the Company Goes Private as It Enters Into Step (2) of Its Growth Transition, Enabling Full Transparency and Revenue Growth
Cannabis Science Enters Transition Stage as Trading of the Company’s Shares is Halted; The Company Will Continue to Implement Its Growth Strategy and Resolve All Outstanding Fully Reporting Requirements
Cannabis Science Partners With CDN Firm NHS Industries to Launch the CBIS CDN Economic Development Plan; CBIS to Use Its Relations With the Harvard International Phytomedicines and Medical Cannabis Institute and Other Leading Institutions
Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally
Cannabis Science Successfully Completes European Headquarters and Operations Move to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations
CBIS LATEST NEWS.
Home
2017
2018
-
2017
-
2016
-
2015
-
2014
-
2013
-
2012
-
2011
-
2010
-
2009
Warning
: Creating default object from empty value in
/home/cannabisscience/public_html/plugins/system/t3/base-bs3/html/com_content/category/default_articles.php
on line
17
Title
Published Date
Cannabis Science Receives Delivery Notifications for First Greenhouse Orders as it Prepares Cannabinoid Observational and Clinical Studies Targeting Several Critical Ailments
08-03-17
Cannabis Science Senior Executives to Co-Chair Special Session and Deliver a Keynote Speech at the Global Health Catalyst Summit at Harvard Medical School
02-03-17
Cannabis Science Announces Update on Proposed DPI Inhalation Device, CBD Infused Pain Patch, and Extends Praise for President Trump's Support of Medical Cannabis, Nationwide
24-02-17
Crown Baus Capital Corp. Acquires 100-Acre Investment Participation in Cannabis Science's California and Nevada Property and Drug Development Projects
17-02-17
Crown Baus Team Negotiates Investment Opportunity with Cannabis Science (CBIS) for Stake in California Property Development Projects and the Nevada Cannabinoid Drug Production Facilities in Douglas County, Nevada
08-02-17
Cannabis Science Distributors Sells Out of Initial Test Batch of CBIS Metered Dose Inhalers (MDI), Notes Consumer High-Demand for the CBIS Inhaler in California
25-01-16
Cannabis Science Distributors Sells Out of Initial Test Batch of CBIS Metered Dose Inhalers (MDI), Notes Consumer High-Demand for the CBIS Inhaler in California
25-01-17
Collaborative Research Agreement with Dana Farber Cancer Institute, Inc.
09-01-17
Cannabis Science Inc. (CBIS) and Dana Farber/Harvard Cancer Center (DF/HCC) Announce Joint Research and Drug Development Agreement; Collaborative Research Agreement
06-01-17
Start
Prev
1
2
3
4
5
Next
End